Rating Change
BMO Capital analysts initiated coverage on Axsome Therapeutics, Inc. (NASDAQ:AXSM) with a Outperform rating on July 21, 2026.
new coverageNASDAQ:AXSM
BMO Capital Initiates Coverage on Axsome Therapeutics, Inc. (AXSM) with Outperform
Rating Change BMO Capital analysts initiated coverage on Axsome Therapeutics, Inc. (NASDAQ:AXSM) with a Outperform rating on July 21, 2026. Market Context Axsome Therapeutics, Inc.
Market Context
Axsome Therapeutics, Inc. operates in the Healthcare sector. The stock currently trades at $233.06 with a market capitalization of $7.5B. The stock has gained 98.4% over the past 52 weeks.
Analyst coverage from BMO Capital provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Axsome Therapeutics, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Axsome Therapeutics, Inc.
Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 21, 2026 | BMO Capital | Outperform | N/A |
| Jul 15, 2026 | HC Wainwright & Co. | Buy | N/A |
| Jul 08, 2026 | HC Wainwright & Co. | Buy | N/A |
| Jul 07, 2026 | RBC Capital | Outperform | N/A |
| Jun 17, 2026 | TD Cowen | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View AXSM Stock Page
Frequently Asked Questions
What does a Outperform rating mean for AXSM?
A Outperform rating from BMO Capital reflects the analyst's outlook on Axsome Therapeutics, Inc. (NASDAQ:AXSM). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the AXSM forecast page.
